Optinose Announces $55 Million Registered Direct Offering
May 9, 2024
Pharmaceuticals
-
-
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
May 9, 2024
-
Zomedica to Present at the EF Hutton Annual Global Conference on May 15, 2024
May 8, 2024
-
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
May 6, 2024
-
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
May 2, 2024
-
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
April 30, 2024
-
Mountain Valley MD Announces Acquisition of Exclusive License for Agrarius, Launch of Performance Guarantee Program
April 24, 2024
-
FSD Pharma Provides Another Update on Celly Nu’s Anticipated Launch of unbuzzd(TM)
April 22, 2024
-
Curaleaf Completes Acquisition of Northern Green Canada
April 22, 2024
-
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product
April 18, 2024
-
PainReform Announces Pricing of $4 Million Public Offering
April 16, 2024
-
Sunshine Biopharma Announces Reverse Stock Split
April 12, 2024
-
Akanda Looks to Commercialize and Capitalize on Germany’s Legalization of Cannabis, Opening Path to $3BN Market
April 12, 2024
-
Akanda Corp. Announces Closing of the Sale of RPK
April 11, 2024
-
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
April 9, 2024
-
Aegis Capital Corp. Acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp. (NASDAQ:FLGC)
April 9, 2024